Pancreatic Cancer Research

ResearcherUniversity of Colorado AnschutzActive in the last 2 years

Angelo D’Alessandro

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-2258-6490; OpenAlex author ID A5045175167. Sources: OpenAlex.

Their work

Papers
8 (first author 0, last author 2)
Trials
0
Grants
0
Labs led
0
Collaborators
26
Papers, trials and grants by year

2013: 1 paper · 2014: none · 2015: none · 2016: none · 2017: none · 2018: none · 2019: 1 paper · 2020: none · 2021: 1 paper · 2022: 1 paper · 2023: 1 paper · 2024: 2 papers · 2025: 1 paper

Papers 8

  1. Lipidome atlas of p53 mutant variants in pancreatic cancer. Co-author DOI 10.1186/s13062-025-00635-w↗
  2. Selective metabolic regulations by p53 mutant variants in pancreatic cancer. Co-author DOI 10.1186/s13046-024-03232-3↗
  3. A Multiomics Assessment of Preoperative Exercise in Pancreatic Cancer Survivors Receiving Neoadjuvant Therapy: A Case Series. Co-author DOI 10.3390/pathophysiology31010013↗
  4. Simultaneous targeting of PD-1 and IL-2Rβγ with radiation therapy inhibits pancreatic cancer growth and metastasis. Co-author DOI 10.1016/j.ccell.2023.04.001↗
  5. p53-driven lipidome influences non-cell-autonomous lysophospholipids in pancreatic cancer. Co-author DOI 10.1186/s13062-022-00319-9↗
  6. Metabolic Characterization of Plasma and Cyst Fluid from Cystic Precursors to Pancreatic Cancer Patients Reveal Metabolic Signatures of Bacterial Infection. Last author DOI 10.1021/acs.jproteome.1c00018↗
  7. The metabolic time line of pancreatic cancer: Opportunities to improve early detection of adenocarcinoma. Last author DOI 10.1016/j.amjsurg.2019.08.015↗
  8. Cannabinoids inhibit energetic metabolism and induce AMPK-dependent autophagy in pancreatic cancer cells. Co-author DOI 10.1038/cddis.2013.151↗

Closest collaborators

The 25 strongest of 26 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Alessio Butera · 3 shared papers, 2022–2025 · strength 0.60
  2. Ivano Amelio · 3 shared papers, 2022–2025 · strength 0.60
  3. Sabrina Caporali · 2 shared papers, 2024–2025 · strength 0.43
  4. Carlotta Zampieri · 2 shared papers, 2022–2024 · strength 0.34
  5. Kirk Charles Hansen · 2 shared papers, 2019–2024 · strength 0.32
  6. Kian Cotton · 1 shared paper, 2025 · strength 0.26
  7. Maria Victoria Niklison-Chirou · 1 shared paper, 2025 · strength 0.26
  8. Travis G. Nemkov · 1 shared paper, 2024 · strength 0.23
  9. Ryan J. Marker · 1 shared paper, 2024 · strength 0.23
  10. Marco Del Chiaro · 2 shared papers, 2019–2021 · strength 0.21
  11. Luigi Leanza · 1 shared paper, 2024 · strength 0.18
  12. Christian Klein · 1 shared paper, 2023 · strength 0.13
  13. Miles Piper · 1 shared paper, 2023 · strength 0.13
  14. Sana D. Karam · 1 shared paper, 2023 · strength 0.13
  15. Ann Morgell · 1 shared paper, 2021 · strength 0.12
  16. Asif Halimi · 1 shared paper, 2021 · strength 0.12
  17. Urban Arnelo · 1 shared paper, 2021 · strength 0.12
  18. Margaret Chen · 1 shared paper, 2021 · strength 0.12
  19. Rogier Aäron Gaiser · 1 shared paper, 2021 · strength 0.12
  20. Roberto Valente · 1 shared paper, 2021 · strength 0.12
  21. Hunter B. Moore · 1 shared paper, 2019 · strength 0.09
  22. Richard David Schulick · 1 shared paper, 2019 · strength 0.09
  23. Elisa Dalla Pozza · 1 shared paper, 2013 · strength 0.04
  24. Marta Palmieri · 1 shared paper, 2013 · strength 0.04
  25. Ilaria Dando · 1 shared paper, 2013 · strength 0.04

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.